Found: 41
Select item for more details and to access through your institution.
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00566-8
- By:
- Publication type:
- Article
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979569
- By:
- Publication type:
- Article
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1286700
- By:
- Publication type:
- Article
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma.
- Published in:
- Frontiers in Genetics, 2019, p. 1, doi. 10.3389/fgene.2019.00740
- By:
- Publication type:
- Article
Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1749, doi. 10.3390/cancers13081749
- By:
- Publication type:
- Article
Multiple Myeloma: Heterogeneous in Every Way.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1285, doi. 10.3390/cancers13061285
- By:
- Publication type:
- Article
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1823, doi. 10.3390/cancers11121823
- By:
- Publication type:
- Article
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1727, doi. 10.3390/cancers11111727
- By:
- Publication type:
- Article
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma.
- Published in:
- Cancers, 2014, v. 6, n. 3, p. 1363, doi. 10.3390/cancers6031363
- By:
- Publication type:
- Article
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma.
- Published in:
- Cancers, 2013, v. 5, n. 2, p. 430, doi. 10.3390/cancers5020430
- By:
- Publication type:
- Article
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.
- Published in:
- Clinical & Experimental Metastasis, 2002, v. 19, n. 7, p. 583, doi. 10.1023/A:1020987830132
- By:
- Publication type:
- Article
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00962-z
- By:
- Publication type:
- Article
Immunosuppressive adenosine - a novel treatment target for multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e137, doi. 10.1016/j.clml.2019.09.228
- By:
- Publication type:
- Article
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01699-3
- By:
- Publication type:
- Article
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0249-x
- By:
- Publication type:
- Article
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
- Published in:
- Acta Ophthalmologica (1755375X), 2008, v. 86, p. 42, doi. 10.1111/j.1755-3768.2008.01185.x
- By:
- Publication type:
- Article
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
- Published in:
- Acta Ophthalmologica (1755375X), 2008, v. 86, p. 35, doi. 10.1111/j.1755-3768.2008.01184.x
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00349
- By:
- Publication type:
- Article
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The F-Actin Content of Multiple Myeloma Cells as a Measure of Their Migration.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 973, n. 1, p. 124, doi. 10.1111/j.1749-6632.2002.tb04620.x
- By:
- Publication type:
- Article
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1016059
- By:
- Publication type:
- Article
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
- Published in:
- Theranostics, 2024, v. 14, n. 7, p. 2656, doi. 10.7150/thno.91456
- By:
- Publication type:
- Article
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02250-3
- By:
- Publication type:
- Article
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 2, p. 112, doi. 10.1002/path.6066
- By:
- Publication type:
- Article
Targeting the β<sub>2</sub>‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
- Published in:
- Journal of Pathology, 2023, v. 259, n. 1, p. 69, doi. 10.1002/path.6020
- By:
- Publication type:
- Article
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
- Published in:
- Journal of Pathology, 2017, v. 241, n. 4, p. 534, doi. 10.1002/path.4860
- By:
- Publication type:
- Article
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
- Published in:
- Journal of Pathology, 2016, v. 239, n. 2, p. 162, doi. 10.1002/path.4712
- By:
- Publication type:
- Article
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK- STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 5, p. 651, doi. 10.1111/bjh.13092
- By:
- Publication type:
- Article
Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 5, p. 1, doi. 10.1002/cti2.1132
- By:
- Publication type:
- Article
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00535-1
- By:
- Publication type:
- Article
Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0065075
- By:
- Publication type:
- Article
The Effects of Forodesine in Murine and Human Multiple Myeloma Cells.
- Published in:
- Advances in Hematology, 2010, v. 2010, p. 1, doi. 10.1155/2010/131895
- By:
- Publication type:
- Article
Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo.
- Published in:
- Stem Cells, 2012, v. 30, n. 2, p. 266, doi. 10.1002/stem.787
- By:
- Publication type:
- Article
The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells.
- Published in:
- BMC Cell Biology, 2002, v. 3, p. 7, doi. 10.1186/1471-2121-3-7
- By:
- Publication type:
- Article
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00303-z
- By:
- Publication type:
- Article
Targeting phosphoglycerate dehydrogenase in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-020-00196-w
- By:
- Publication type:
- Article
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 8, p. 1857, doi. 10.1002/ijc.22845
- By:
- Publication type:
- Article
Metabolic Features of Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 1200, doi. 10.3390/ijms19041200
- By:
- Publication type:
- Article
The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 4, p. 469, doi. 10.1111/j.1365-2141.2005.05886.x
- By:
- Publication type:
- Article
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 904, doi. 10.3390/ijms23020904
- By:
- Publication type:
- Article
Single-cell analysis at the protein level delineates intracellular signaling dynamic during hematopoiesis.
- Published in:
- BMC Biology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12915-021-01138-6
- By:
- Publication type:
- Article